For orthopedic surgeons wondering where the big reconstructive companies are finding growth these days, Zimmer Biomet’s second-quarter 2026 numbers provide a fairly concise answer: hips are healthy, sports medicine and extremities are moving, technology is sprinting—and knees, the company’s largest product category, are taking their time.
Company News Premium
Zimmer Biomet Mid-Year Report: Hips Move but Knees Take the Scenic Route
1 min read Premium comments

Zimmer Biometearningsorthopedics saleship salesknee salescash flow
Author
React:
